肌肉减少症研究进展
Research Progress of Sarcopenia
DOI: 10.12677/ACM.2023.1351235, PDF,   
作者: 段 苗:西安医学院研工部,陕西 西安;史丽萍*:陕西省人民医院消化内二科,陕西 西安
关键词: 肌少症老年人发病机制慢性合并症Sarcopenia Elderly Pathogenesis Chronic Comorbidities
摘要: 肌肉减少症(sarcopenia) (简称肌少症)是一种进行性和全身性骨骼肌疾病,涉及肌肉力量减低、肌肉质量下降和躯体功能的加速丧失,与跌倒、功能衰退、虚弱和死亡率等不良后果增加有关,分为与年龄相关的原发性肌肉减少症及由慢性疾病所致的继发性肌肉减少症。随着世界人口的老龄化,肌少症的患病率总体来说呈上升趋势。因此,早期识别并采取有效干预措施延缓肌少症的发生十分必要。本文从肌少症的概念、发病机制、合并常见慢性病等方面进行综述,旨在提高临床工作者对肌少症的认识从而提高老年人群生活质量、减轻医疗保健系统的负担。
Abstract: Sarcopenia (abbreviated as sarcopenia) is a progressive and systemic skeletal muscle disease that involves decreased muscle strength, decreased muscle mass, and accelerated loss of physical func-tion. It is associated with increased adverse consequences such as falls, functional decline, weak-ness, and mortality. It can be divided into age-related primary sarcopenia and secondary sarcope-nia caused by chronic diseases. With the aging of the world population, the overall incidence of sar-copenia is on the rise. Therefore, early identification and effective intervention measures are nec-essary to delay the occurrence of sarcopenia. This article reviews the concept, pathogenesis, and common chronic diseases of sarcopenia, aiming to enhance clinical workers’ understanding of sar-copenia, improve the quality of life of the elderly population, and reduce the burden on the healthcare system.
文章引用:段苗, 史丽萍. 肌肉减少症研究进展[J]. 临床医学进展, 2023, 13(5): 8836-8844. https://doi.org/10.12677/ACM.2023.1351235

参考文献

[1] Cruz-Jentoft, A.J. and Sayer, A.A. (2019) Sarcopenia. The Lancet, 393, 2636-2646. [Google Scholar] [CrossRef
[2] Rosenberg, I.H. (1997) Sarcopenia: Origins and Clinical Relevance. The Journal of Nutrition, 127, 990S-991S. [Google Scholar] [CrossRef
[3] Cruz-Jentoft, A.J., Baeyens, J.P. and Bauer, J.M. (2010) Sarcopenia: European Consensus on Definition and Diagnosis: Report of the European Working Group on Sarcopenia in Older Peo-ple. Age Ageing, 39, 412-423. [Google Scholar] [CrossRef] [PubMed]
[4] Chen, L.K., Liu, L.K. and Woo, J. (2014) Sarcopenia in Asia: Consen-sus Report of the Asian Working Group for Sarcopenia. Journal of the American Medical Directors Association, 15, 95-101. [Google Scholar] [CrossRef] [PubMed]
[5] Cruz-Jentoft, A.J., Bahat, G. and Bauer, J. (2019) Sarcopenia: Revised European Consensus on Definition and Diagnosis. Age Ageing, 48, 16-31. [Google Scholar] [CrossRef] [PubMed]
[6] Chen, L.K., Woo, J. and Assantachai, P. (2020) Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. Journal of the American Medical Di-rectors Association, 21, 300-307.e2. [Google Scholar] [CrossRef] [PubMed]
[7] Anker, S.D., Morley, J.E. and von Haehling, S. (2016) Welcome to the ICD-10 Code for Sarcopenia. Journal of Cachexia, Sarcopenia and Muscle, 7, 512-514. [Google Scholar] [CrossRef] [PubMed]
[8] 刘娟, 丁清清, 周白瑜. 中国老年人肌少症诊疗专家共识(2021) [J]. 中华老年医学杂志, 2021, 40(8): 943-952. [Google Scholar] [CrossRef
[9] Mayhew, A.J., Amog, K. and Phillips, S. (2019) The Prevalence of Sarcopenia in Community-Dwelling Older Adults, an Exploration of Differences between Studies and within Definitions: A Systematic Review and Meta-Analyses. Age Ageing, 48, 48-56. [Google Scholar] [CrossRef] [PubMed]
[10] Bischoff-Ferrari, H.A., Orav, J.E., Kanis, J.A. and Rizzoli, R. (2015) Comparative Performance of Current Definitions of Sarcopenia against the Prospective Incidence of Falls among Com-munity-Dwelling Seniors Age 65 and Older. Osteoporosis International, 26, 2793-2802. [Google Scholar] [CrossRef] [PubMed]
[11] Xin, C., Sun, X. and Lu, L. (2021) Prevalence of Sarcopenia in Older Chinese Adults: A Systematic Review and Meta-Analysis. BMJ Open, 11, e041879. [Google Scholar] [CrossRef] [PubMed]
[12] Makizako, H., Nakai, Y. and Tomioka, K. (2019) Prevalence of Sarcopenia Defined Using the Asia Working Group for Sarcopenia Criteria in Japanese Community-Dwelling Older Adults: A Systematic Review and Meta-Analysis. Physical Therapy Research, 22, 53-57. [Google Scholar] [CrossRef
[13] Choo, Y.J. and Chang, M.C. (2021) Prevalence of Sarcopenia among the Elderly in Korea: A Meta-Analysis. Journal of Preventive Medicine and Public Health, 54, 96-102. [Google Scholar] [CrossRef] [PubMed]
[14] Pamoukdjian, F., Bouillet, T. and Levy, V. (2018) Prevalence and Pre-dictive Value of Pre-Therapeutic Sarcopenia in Cancer Patients: A Systematic Review. Clinical Nutrition, 37, 1101-1113. [Google Scholar] [CrossRef] [PubMed]
[15] Goodman, C.A. (2014) The Role of mTORC1 in Regulating Pro-tein Synthesis and Skeletal Muscle Mass in Response to Various Mechanical Stimuli. Reviews of Physiology, Biochemis-try and Pharmacology, 166, 43-95. [Google Scholar] [CrossRef] [PubMed]
[16] Bano, G., Trevisan, C. and Carraro, S. (2017) Inflammation and Sarco-penia: A Systematic Review and Meta-Analysis. Maturitas, 96, 10-15. [Google Scholar] [CrossRef] [PubMed]
[17] Ebadi, M., Bhanji, R.A. and Mazurak, V.C. (2019) Sarcopenia in Cirrhosis: From Pathogenesis to Interventions. Journal of Gastroenterology, 54, 845-859. [Google Scholar] [CrossRef] [PubMed]
[18] Nardone, O.M., de Sire, R. and Petito, V. (2021) Inflammatory Bowel Diseases and Sarcopenia: The Role of Inflammation and Gut Microbiota in the Development of Muscle Failure. Frontiers in Immunology, 12, Article ID: 694217. [Google Scholar] [CrossRef] [PubMed]
[19] Marzetti, E., Calvani, R. and Cesari, M. (2013) Mitochondrial Dysfunction and Sarcopenia of Aging: From Signaling Pathways to Clinical Trials. The International Journal of Bio-chemistry & Cell Biology, 45, 2288-2301. [Google Scholar] [CrossRef] [PubMed]
[20] Lee, H.K., Rocnik, E. and Fu, Q. (2012) Foxo/Atrogin Induction in Human and Experimental Myositis. Neurobiology of Disease, 46, 463-475. [Google Scholar] [CrossRef] [PubMed]
[21] Dimitriadis, G., Mitrou, P., Lambadiari, V., et al. (2011) Insulin Effects in Muscle and Adipose Tissue. Diabetes Research and Clinical Practice, 93, S52-S59. [Google Scholar] [CrossRef
[22] Mirzoev, T.M. and Shenkman, B.S. (2018) Regulation of Protein Synthesis in Inactivated Skeletal Muscle: Signal Inputs, Protein Kinase Cascades, and Ribosome Biogenesis. Bi-ochemistry (Mosc), 83, 1299-1317. [Google Scholar] [CrossRef
[23] Shin, M.J., Jeon, Y.K. and Kim, I.J. (2018) Testosterone and Sarcopenia. The World Journal of Men’s Health, 36, 192-198. [Google Scholar] [CrossRef] [PubMed]
[24] Remelli, F., Vitali, A. and Zurlo, A. (2019) Vitamin D Deficiency and Sarcopenia in Older Persons. Nutrients, 11, Article No. 2861. [Google Scholar] [CrossRef] [PubMed]
[25] Dzik, K.P. and Kaczor, J.J. (2019) Mechanisms of Vitamin D on Skeletal Muscle Function: Oxidative Stress, Energy Metabolism and Anabolic State. European Journal of Applied Physi-ology, 119, 825-839. [Google Scholar] [CrossRef] [PubMed]
[26] Clynes, M.A., Gregson, C.L. and Bruyere, O. (2021) Osteosar-copenia: Where Osteoporosis and Sarcopenia Collide. Rheumatology (Oxford), 60, 529-537. [Google Scholar] [CrossRef] [PubMed]
[27] Reiss, J., Iglseder, B. and Alzner, R. (2019) Sarcopenia and Osteoporosis Are Interrelated in Geriatric Inpatients. Zeitschrift für Gerontologie und Geriatrie, 52, 688-693. [Google Scholar] [CrossRef] [PubMed]
[28] Locquet, M., Beaudart, C. and Reginster, J.Y. (2019) Associa-tion between the Decline in Muscle Health and the Decline in Bone Health in Older Individuals from the SarcoPhAge Cohort. Calcified Tissue International, 104, 273-284. [Google Scholar] [CrossRef] [PubMed]
[29] Da Silva, A.P., Matos, A. and Ribeiro, R. (2017) Sarcopenia and Osteoporosis in Portuguese Centenarians. European Journal of Clinical Nutrition, 71, 56-63. [Google Scholar] [CrossRef] [PubMed]
[30] Kirk, B., Zanker, J. and Duque, G. (2020) Osteosarcopenia: Epidemiol-ogy, Diagnosis, and Treatment-Facts and Numbers. Journal of Cachexia, Sarcopenia and Muscle, 11, 609-618. [Google Scholar] [CrossRef] [PubMed]
[31] Dos Santos, Pinto, D. and Kloeckner, R. (2020) Sarcopenia as Prognostic Factor for Survival after Orthotopic Liver Transplantation. European Journal of Gastroenterology & Hepatology, 32, 626-634. [Google Scholar] [CrossRef
[32] Tantai, X., Liu, Y. and Yeo, Y.H. (2022) Effect of Sarco-penia on Survival in Patients with Cirrhosis: A Meta-Analysis. Journal of Hepatology, 76, 588-599. [Google Scholar] [CrossRef] [PubMed]
[33] Sinclair, M., Gow, P.J. and Grossmann, M. (2016) Review Article: Sarcopenia in Cirrhosis—Aetiology, Implications and Potential Therapeutic Interventions. Alimentary Pharmacology & Therapeutics, 43, 765-777. [Google Scholar] [CrossRef] [PubMed]
[34] Ebadi, M., Bhanji, R.A. and Mazurak, V.C. (2019) Sarcopenia in Cirrhosis: From Pathogenesis to Interventions. Journal of Gastroenterology, 54, 845-859. [Google Scholar] [CrossRef] [PubMed]
[35] Ryan, E., McNicholas, D. and Creavin, B. (2019) Sarcopenia and Inflammatory Bowel Disease: A Systematic Review. Inflammatory Bowel Diseases, 25, 67-73. [Google Scholar] [CrossRef] [PubMed]
[36] Jeejeebhoy, K.N. and Duerksen, D.R. (2018) Malnutrition in Gastrointesti-nal Disorders: Detection and Nutritional Assessment. Gastroenterology Clinics of North America, 47, 1-22. [Google Scholar] [CrossRef] [PubMed]
[37] Balestrieri, P., Ribolsi, M., Guarino, M.P.L. and Emerenziani, S. (2020) Nutritional Aspects in Inflammatory Bowel Diseases. Nutrients, 12, 372. [Google Scholar] [CrossRef] [PubMed]
[38] Ticinesi, A., Mancabelli, L. and Tagliaferri, S. (2020) The Gut-Muscle Axis in Older Subjects with Low Muscle Mass and Performance: A Proof of Concept Study Exploring Fecal Microbiota Composition and Function with Shotgun Metagenomics Sequencing. International Journal of Molecular Sciences, 21, 8946. [Google Scholar] [CrossRef] [PubMed]
[39] Liu, S., Ding, X. and Maggiore, G. (2022) Sarcopenia Is Associ-ated with Poor Clinical Outcomes in Patients with Inflammatory Bowel Disease: A Prospective Cohort Study. Annals of Translational Medicine, 10, 367. [Google Scholar] [CrossRef] [PubMed]
[40] Anagnostis, P., Gkekas, N.K. and Achilla, C. (2020) Type 2 Diabetes Mellitus Is Associated with Increased Risk of Sarcopenia: A Systematic Review and Meta-Analysis. Calcified Tissue In-ternational, 107, 453-463. [Google Scholar] [CrossRef] [PubMed]
[41] Mori, H., Kuroda, A. and Ishizu, M. (2019) Association of Ac-cumulated Advanced Glycation End-Products with a High Prevalence of Sarcopenia and Dynapenia in Patients with Type 2 Diabetes. Journal of Diabetes Investigation, 10, 1332-1340. [Google Scholar] [CrossRef] [PubMed]
[42] Sugimoto, K., Ikegami, H. and Takata, Y. (2021) Glycemic Control and Insulin Improve Muscle Mass and Gait Speed in Type 2 Dia-betes: The MUSCLES-DM Study. Journal of the American Medical Directors Association, 22, 834-838. e1. [Google Scholar] [CrossRef] [PubMed]
[43] Narasimhulu, Aluganti, C. and Singla, D.K. (2021) Amelioration of Diabetes-Induced Inflammation Mediated Pyroptosis, Sarcopenia, and Adverse Muscle Remodelling by Bone Mor-phogenetic Protein-7. Journal of Cachexia, Sarcopenia and Muscle, 12, 403-420. [Google Scholar] [CrossRef] [PubMed]
[44] Tsekoura, M., Tsepis, E. and Billi, E. (2020) Sarcopenia in Patients with Chronic Obstructive Pulmonary Disease: A Study of Prevalence and Associated Factors in Western Greek Population. Lung India, 37, 479-484. [Google Scholar] [CrossRef] [PubMed]
[45] Sepulveda-Loyola, W., Osadnik, C. and Phu, S. (2020) Diagnosis, Prevalence, and Clinical Impact of Sarcopenia in COPD: A Systematic Review and Meta-Analysis. Journal of Cachexia, Sarcopenia and Muscle, 11, 1164-1176. [Google Scholar] [CrossRef] [PubMed]
[46] Ito, A., Hashimoto, M. and Tanihata, J. (2022) Involvement of Par-kin-Mediated Mitophagy in the Pathogenesis of Chronic Obstructive Pulmonary Disease-Related Sarcopenia. Journal of Cachexia, Sarcopenia and Muscle, 13, 1864-1882. [Google Scholar] [CrossRef] [PubMed]
[47] Van Bakel, S.I.J., Gosker, H.R., Langen, R.C. and Schols, A.M.W.J. (2021) Towards Personalized Management of Sarcopenia in COPD. International Journal of Chronic Obstructive Pul-monary Disease, 16, 25-40. [Google Scholar] [CrossRef
[48] Sancho-Munoz, A., Guitart, M. and Rodriguez, D.A. (2021) Defi-cient Muscle Regeneration Potential in Sarcopenic COPD Patients: Role of Satellite Cells. Journal of Cellular Physiology, 236, 3083-3098. [Google Scholar] [CrossRef] [PubMed]
[49] Warnken-Miralles, M.D., Lopez-Garcia, F. and Zamora-Molina, L. (2021) Sarcopenia Index in Hospitalized Patients with Chronic Obstructive Pulmonary Disease Exacerbation. Medicina (B Aires), 81, 323-328.
[50] Kashani, K.B., Frazee, E.N. and Kukralova, L. (2017) Evaluating Muscle Mass by Using Markers of Kidney Function: Development of the Sarcopenia Index. Critical Care Medicine, 45, e23-e29. [Google Scholar] [CrossRef
[51] Wu, Y.K., Li, M. and Zhang, Y.C. (2022) The Sarcopenia Index Is an Effective Predictor for Malnutrition in Patients with Liver Cirrhosis. Nutrition & Dietetics, 79, 563-571. [Google Scholar] [CrossRef] [PubMed]
[52] Zhao, X., Su, R. and Hu, R. (2023) Sarcopenia Index as a Predictor of Clinical Outcomes among Older Adult Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Cross-Sectional Study. BMC Geriatrics, 23, Article No. 89. [Google Scholar] [CrossRef] [PubMed]
[53] Ge, J., Zeng, J. and Ma, H. (2022) A New Index Based on Se-rum Creatinine and Cystatin C Can Predict the Risks of Sarcopenia, Falls and Fractures in Old Patients with Low Bone Mineral Density. Nutrients, 14, 5020. [Google Scholar] [CrossRef] [PubMed]
[54] Tang, T., Xie, L. and Hu, S. (2022) Serum Creatinine and Cystatin C-Based Diagnostic Indices for Sarcopenia in Advanced Non-Small Cell Lung Cancer. Journal of Cachexia, Sarcopenia and Muscle, 13, 1800-1810. [Google Scholar] [CrossRef] [PubMed]
[55] Zheng, C., Wang, E. and Li, J.S. (2022) Serum Creatinine/Cystatin C Ratio as a Screening Tool for Sarcopenia and Prognostic Indicator for Patients with Esophageal Cancer. BMC Geriatrics, 22, Article No. 207. [Google Scholar] [CrossRef] [PubMed]
[56] Xu, X., Chen, Y. and Cai, W. (2023) A Multivariable Model Based on Ultrasound Imaging Features of Gastrocnemius Muscle to Identify Patients with Sarcopenia. Journal of Ultra-sound in Medicine. [Google Scholar] [CrossRef] [PubMed]
[57] Zhu, K., Wactawski-Wende, J. and Ochs-Balcom, H.M. (2021) The Association of Muscle Mass Measured by D3-Creatine Dilution Method with Dual-Energy X-Ray Absorp-tiometry and Physical Function in Postmenopausal Women. The Journals of Gerontology Series A Biological Sciences and Medical Sciences, 76, 1591-1599. [Google Scholar] [CrossRef] [PubMed]